BIBLIOGRAFIA
1. Levi e Pange 1996 2. Still, 1902
3. P.M. Bailey: Carcinosinum, Salus Infirmorum, Padova, 2006 4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder. Fourth Edition.Washington, DC.
2001
5. NIH: Consensus Development Conference Statement, Nov 16-18, 1988
6. Carey WB:ADHD gli interrogativi non risolti. Quaderni acp 2004;11 (6):236-241
7. APA,1994
8. Brown T.E.:Attention deficit disorder and comorbidities in children, adolescents and adults. Washington, DC, American Psychiartic Press, 2000
9. Dandy C.: 5 Components of executive function. 26-31, febbraio 2002
10. American Psychiatric Assiciation: Diagnostic and Statistical Manual of Mental Disorder.. Fourth Edition, Text Revision.
Washington, DC, 2001 11. C-GAS; Shaffer et al. 1983 12. Ickowicz et al. 2002 13. DuPaul et al 1008
14. DSM IV, modificato da DSM IV APA 1995 e Scale SDAG Cornoldi, Gardinale, Masi, Pettenò, 1996
15. www.healing-arts.org/children/ADHD
16. Jansen F, Streit U: Eltern asl Therapeuten 1993 17. cfr in S. Corbo, F. Marolla, V. Sarno, M.G. Torrioli, S.
Vernacotola, il bambino iperattivi e disattento, Franco Angeli, 2002, pag. 14
18. MTA Cooperative Group: A 14-month RCT of treatment for ADHD. Arch. Gen. Psych.,56,12,(1999)
19. Biedermann J. AD/HD. A life span perspective. J Clin. Psych. 59 (suppl. 7):14-16,1999
20. Pliszka S.R.Comorbidity of ADHD with psychiatric disorder: an overview. J Clin. Psych. 59 (suppl. 7):50-55. 1998
21. www.healing-arts.org/children/ADHD
22. Dopfner, Frohlic, Lehmkuhl: Hyperkinestische Storungen 2000 23. Lou HC, Henriksen L, Bruhn P et al.1998, Striatal dysfunction in
attention deficit and hyperkinetic disorder, Arch. Neurol 46(1):48- 52
24. Helen Courvoisie, Stephen R. Hooper, Camille Fine, Lester Kwock, and Mauricio Castillo: Neurometabolic Function and Neuropsychological Correlates in Children with ADHD-H:
Preliminary Findings. J Neuropsychiatry Clin Neuroscience , Feb 2004;16:63-69
25. Zanetkin A, Rapaport JL: Neurobiology of Attenction Deeficit Disorder with Hyperactivity: Where Have We Come in 50 Years?, J Am Acad Child Adol Psychiatry 26:676-686, 1987
26. Castellanos FX et al., Quantitative brain MRI and AHD. Arch Gen Psychiatry, 1996; 53:607-616
27. Swanson JM et al,: Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit disorder (ADHD): a family-based approach. Mol Psychiatry 1998; 3:38-41 28. Biederman J.: Pattern of psychiatric comorbidity, cognition, and
psychosocial functioning in adults with attention deficit hiperactivity disorder. Am Psychiatry 1993; 150:1792-8
29. Biederman J.: A prospective 4-year follow-up study of attention- deficit hyperactivity and related disorder. Arch Gen Psychiatry 1996; 53:437-46
30. Swanson 1998
31. Rucco L.A., Viggiano D., Pignatelli M., Iannaccone T., Rimoli m.g., Melisi D., Curcio A., “Galactosilated dopamine increases
attention without reducing activity in C57BL/6 mice”, Behav Brain Res,2007
32. Cabib S.,Puglisi-Allegra S. e Ventura R.,” The contriution of comparative studies in inbed strains of mice to the understanding of hyperactivity phenotype”, Behav Bran Res, 2002
33. Rucco L.A., Viggiano D., Abignente E., Rimoli M.G., Melisi D., Curcio A., Nieddu M., Carboni E., Salide A.G., “Galactosilated dopamine enter into the brain, bloks mesocorticolimbic system and modulates activity and scanning time in naples high exitability rats” Neuroscience, 2007
34. Katzung B.G.,2000 35. Katzung B.G.,2000 36. Goodman e Gilman 1997 37. Katzung B.G.,2000
38. Begley D.J. “The blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System”
39. Solano M.V. 1998
40. Faraone and Kahn 2006; Waldman and Gizer 2006 41. Cook et al. 1995
42. Curran et al. 2001b; Swanson et al. 2000b; Todd et al. 2001a;
Waldman et el. 1998 43. PI-Dr. Stephen Faraone 44. Vandenbergh et al. 1992 45. Ciliax et al. 1999
46. Giros et al. 1996 47. Vandenberg et al.1992 48. Doucette-Stamm te al. 1995 49. Jacobsen et al. 2000
50. Heinz et al. 2000
51. Brookes et al., Mill et al. 2002
52. Asherson et al. 2007; Brookes et al 2006; Curran et al. 2001;
Feng et al. 2005; Galili-Weissutub and Segman 2003; Hebebrand
et al. 2006; Kim et al. 2005; Kustanovich et al. 2004; Lim et al.
2006; Maher et al. 2002 53. Brookes et al. 2007 54. Brookes et al. 2006b
55. Asherson et al. 2007; Brookes et al 2006; Mick et al. Data non pubblicata
56. Galili-Weisstub and Segman 2003 57. Genro et al. 2008; Guan et al. 2008
58. Brookes et al. 2006; Feng et al. 2005b; Friedel et al. 2007; Galili- Weisstub and Segman 2003; Mick et al. unpublished data
59. Mill et al. 2005; Waldman et al 1998
60. Becker et al. 2008; Brookes et al. 2006b; Kahn et al. 2003;
Langley et al. 2008; Neuman et al. 2007 61. Faraone e Asherson 2005
62. Oldenhof et al. 1998
63. Gelernter et al. 1992; Petronis et al. 1993 64. Levy 1991
65. Floresco and Tse 2007, Noain et al. 2006 66. Benjamin et al. 1996; Ebstein et al. 1996 67. Rubinstein et al. 1997
68. Chang et al. 1996; Van Tol et al. 1992 69. Asghari et al. 1995
70. Arcos-Burgos et al. 2004a; Brookes et al. 2006a; Kustanovich et al. 2004; Lunetta et al. 2000; Maher et al. 2002; Mick et al.
Unpublished data; Sunohara et al. 2000; Tahir et al.2000b; Todd et al. 2001b
71. Bakker et al. 2005; Bhaduri et al. 2006; Carrasco et al. 2006;
Curran et al. 2001b; El-Faddagh et al. 2004; Frank et al. 2004;
Gornick et al. 2007; Hawi et al. 2000A; Holmes et al. 2000a;
Kotler et al. 2000; LaHoste et al. 1996; Mill et al.2001; Roman et al. 2001; Rowe et al. 1998; Smith et al. 2003; Swanson et al. 1998 72. Seaman et al. 1999
73. McCracken et al. 2000
74. Kustanovich et al. 2004 75. Kereszturi et al. 2007 76. Okuyama et al. 1999
77. Barr et al. 2001; Lowe et al. 2004b; Payton et al. 2001 78. Barr et al. 2001; Lowe et al. 2004b; Payton et al. 2001
79. Lasky-Su et al. 2007; Lasky-Su 2008; McCraken et al 2000; Rowe et al. 1998
80. Kebir et al. 2009 81. Andersen et al. 1990 82. Eubanks et al. 1992 83. Usiello et al. 2000
84. Blum et al. 1990; Noble et al. 1991 85. Neville et al. 2004
86. Laasko et al. 2005; Thompson et al 1997 87. Ponce et al. 2004
88. Kirley et al.2002; Kustanovich et al. 2004; Rowe et al. 1999 89. Huanget al. 2003; Kopeckova et al. 2008; Sery et al. 2006 90. Huang et al.2003; Kirley et al. 2002; Rowe et al. 1999 91. Sunahara et al. 1991
92. Sherrington et al. 1993 93. Beischlag et al 1995 94. Li et al. 2003
95. Sherrington et al. 1993 96. Hoenicka et al. 2007 97. Daly et al. 1999 98. Li et al. 2006a 99. Vallone et al. 2000 100. Le Coniat et al. 1991
101. Beinger e Banasikowsky 2008 102. Barr et al. 2000b
103. Brookes et al. 2006a; Guan et al.2008 104. Hong et al. 1998
105. Pennington e Ozonoff 1996; Schulz et al. 2004; Willcut et al.
2005
106. Lotta et al. 1995; Scanlon et al 1979; Weinshilboum e Dunette 1981
107. Cheuk e Wong 2006
108. Biederman et al. 2008; Qian et al. 2003 109. Craig et al. 1998
110. Biederman e Faraone 2002; Pliszka et al. 1996
111. Hinshaw et al. 1987; Bowden et al. 1988; Rogeness et al. 1989 112. Gelernter et al. 1993
113. Pacholczyk et al.1991 114. Stahl 2003
115. Solanto 1998
116. Michelson et al. 2002; Spencer et al. 2002 117. Yang-Feng et al.1987
118. Arnsten 2006
119. Arnsten e Li 2005; wALDMAN ET AL. 2006 120. Pennington e Ozonoff 1996; Willcutt et al. 2005 121. Andrews e Lavin 2006
122. Xu et al. 2001
123. Romano et al.2003; Schmitz et al. 2006 124. Gelernter et al. 1995
125. Heils et al.1996; Lesch et al. 1996 126. Frankle et al. 2004; Oquendo et al. 2007
127. Halperin et al. 1997; Spivak et al.1999; Stein et al. 1993 128. Gainetdinov et al. 1999
129. Lotrich e Pollock 2004; Munafo et al 2005; Schinka et al 2004; Sen et al. 2004
130. Williams et al. 2003
131. Nobile et al. 1999; Greenberg et al. 1999 132. Nobile et al. 1999; Greenberg et al. 1999 133. Nobile et al. 1999; Greenberg et al. 1999 134. Nobile et al. 1999; Greenberg et al. 1999
135. Battaglia et al. 1999 136. Kent et al. 2002
137. Halperin et al.1997; Spivak et al. 1999 138. Heiser et al. 2007; Ribases et al. 1992 139. Jin et al. 1992
140. Demchyshyn et al. 1992 141. Murphy et al. 1998 142. Ichikawa et al. 2005
143. Brunner e Hen 1997; Saudou et al. 1994 144. Hawi et al. 2002
145. Sparacino et al.1991 146. Chen et al. 1992 147. Lesch, 2001
148. Dwivedi e Pandey 1998 149. O'Neill et al.1999 150. Martin et al. 1998
151. Erdmann et al.1996;Ozaki et al.1996 152. Warren et al.1992
153. Quist et al.2000 154. Craig et al. 1991 155. Walther et al.2003 156. Oswald et al. 2004 157. Walitza et al.2005 158. Sheehan et al. 2005 159. Brookes et al. 2006a 160. Zametkin et al. 1985 161. Brunner et al. 2993 162. Cause et al. 1998
163. Caspi et al. 2002; Manuck et al. 2000
164. Sistema di calassificazione Deckert et al. 1999 165. Deckert et al. 1999
166. Caspi et al.2002; Manuck et al. 2000 167. Levin 2002
168. Wilens et al. 2006
169. Fung e Lau 1988; Grady et al.1992 170. Steinlein et al. 1995
171. Maglott et al. 1996 172. Hess et al. 1992 173. Sollner et al. 1993 174. Mattson 2008
175. Hashimoto et al. 2004 176. Maisonpierre et al. 1991 177. Guillin et al. 2001
178. Hall et al.2003; Horger et al. 1999 179. Tsai 2003
180. Chen et al. 2004; Egan et al. 2003
181. Brookes et al.2006a; Kent et al. 2005; Lee et al. 2007 182. Friedel et al. 2005; Guan et al. 2008; Xu et al. 2007b 183. Lee et al. 2007; Kent et al. 2005
184. Xu et al. 2006
185. Brookes et al. 2006a; Guan et al. 2008; Hawi et al. 2001;
Ribases et al. 2009
186. Misener et al. 2004; Bobb ET AL. 2005 187. Ribases et al. 2009
188. Swanson et al 1998
189. America Pscichiatryc Association DSM 1994; American Accademy of Pediatrics DSM-PC 1996
190. Posner e Petrson 1990 191. Barkley 1997; 1998 192. Barkley 1998
193. Schacher e Logan 1990; Barkley 1997 194. Quay 1988
195. LOU et al. 1998; Swanson et al 1998
196. Casey et al. 1997; Catellanos et al. 1996; Filipek et al. 1997;
Mataro et al. 1997
197. Silberstain et al. 1998; Zametkin et al. 1990
198. Pochon et al. 2002 199. Goldman e Rakic 1990
200. Cook et al. 1995; LaHoste et al. 1996; Smalley et al. 1998;
Waldman et al. 1998; Sunohara et al. 1999; Barr 2001 201. Fisher et al. 2002
202. Taylor et al. 1996; NICE 2000; AACAP 2002
203. Cantwell 1996; Elia et al. 1998; Guevara e Stein 2001 204. Taylor et al. 1998
205. NICE 200, Santosh e Taylor 2000 206. Cantwell 1996; Mannuzza et al. 2000 207. Taylor et al. 1996
208. Spencer et al. 1996; AACAP 2002
209. Arnsten et al. 1996; Biederman e Spencer 2000 210. Stubbe e Weiss 2000
211. Spencer et al. 1996; Santosh e Taylor 2000; AACAP 2002 212. Volkow et al. 1998; Santosh e Taylor 2000
213. Volkow et al. 1998
214. Solanto 1998; Zhuang et al. 2001 215. Seeman e Madras 1998
216. Klorman et al. 1991 217. O'Toule et al. 1993 218. Gadow et al. 1990
219. Aman MG, Langworthy KS (october 2000) “Pharmacotherapy for hyperactivity in children with autism and other pervasive development disorder”. J Autism Dev Disord 30 (5): 451-9 220. Jahromi LB, Kasari CL, McCracken JT, et al. (March 2009)
“Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorder and hyperactivity” J Autism Dev Disord 39 (3): 395-404
221. Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert- Noodt G (2006) “Influence of methylphenidate on brain development-an update of racant animal experiments” Behav Brain Funct 2:2
222. Myers Richard, the 100 most important chemical compound 2007-08
223. New Brookhaven Lab Study Shows How Ritalin Works;
Gottlieb Scott 2001
224. “Il ruolo della dopamina nella schizofrenia e il meccanismo d’azione degli antipsicotici: dagli antagonisti ai parziali
agonisti”. Maria del Zompo, Giovanni Severino Sezione di Farmacologia Clinica, Centro di Psicofarmacologia Clinica, Dipartimento di Neuroscienze, Università degli Studi di Cagliari 225. NIH 1998
226. Edmund J.S. Sonuga-Bbarke, Margaret Thompson, Howard Abikoff, Rachel Klein, Laurie Miller Brotman.
“Nonpharmacological Intervention for Preschoolers With ADHD:
The case for Specialized Parent Training”. 2008
227. Dafny N, Yang PB (february 2006). “The role of age, genotype, sex, and route of acute and chronic administration of methylphenidtae: a rewiew of its locomotor effects” Brain Research Bulletin 68 (6):393-450
228. “Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder”. Am J Psychiatry 163 (7): 1149-52.): (scharman EJ, Erdman AR, Cobaugh DJ, et al. (2007)
229. “Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management” Clinical Toxicology 45 (7):737-52
230. Volokow e Swanson 2003
231. Odd Ratio 1.9; Wilens et al. 2003 232. Taylor et al. 2004
233. Velasquez-Tirado JD, Pena JA (2005). “Evidencia effettivo sobre la atomoxetina. Alternativa terapeutica para el trastorno por deficit de atencion hiperactividad”. Revista de Neurologia 41 (8). 493-500
234. Patent and Exclusivity Search Results”. Electronic Orange Book. US Food and Drug Administration. April 2009
235. Carboni et al. 1990; Moron et al. 2002 236. Bymaster et al. 2002; Swanson et al. 2006 237. Bymaster 2002
238. Swanson 2006
239. Kratochvil et al. 2005 240. Biek et al. 2005 241. Michelson et al. 2002 242. Kelesy et al 2004 243. Weiss et al. 2005 244. Wernicke et al. 2002
